GE HealthCare Technologies Inc.
GEHC | NASDAQ
$64.81
+$0.68 (+1.06%)
At close: Sep 21, 2026, 4:00 PM ET
$64.64
-$0.17 (-0.26%)
After-hours:
Sep 21, 2026, 7:54 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 20.63B | 19.67B | 19.55B | 18.34B | 17.59B | 17.16B |
Cost of Revenue | 12.38B | 11.47B | 11.63B | 11.16B | 10.41B | 10.4B |
Gross Profit | 8.25B | 8.21B | 7.92B | 7.18B | 7.17B | 6.77B |
Operating Income | 2.76B | 2.63B | 2.44B | 2.52B | 2.8B | 2.72B |
Interest Income | n/a | n/a | 26M | n/a | 34M | 49M |
Pretax Income | 2.77B | 2.58B | 2.36B | 2.51B | 2.88B | 2.71B |
Net Income | 2.08B | 1.99B | 1.57B | 1.92B | 2.25B | 13.85B |
Selling & General & Admin | 4.23B | 4.27B | 4.28B | 3.63B | 3.56B | 3.24B |
Research & Development | 1.26B | 1.31B | 1.21B | 1.03B | 816M | 810M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.49B | 5.58B | 5.49B | 4.66B | 4.38B | 4.05B |
Interest Expense | 450M | 505M | 542M | 86M | 40M | 66M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.86B | 17.05B | 17.12B | 15.82B | 14.79B | 14.44B |
Income Tax Expense | 614M | 531M | 743M | 563M | 600M | 652M |
Shares Outstanding (Basic) | 456.52M | 456M | 455M | 453.93M | 454.71M | 454.71M |
Shares Outstanding (Diluted) | 460.27M | 459M | 458M | 453.93M | 454.71M | 454.71M |
EPS (Basic) | 4.56 | 4.37 | 3.04 | 4.22 | 4.90 | 4.41 |
EPS (Diluted) | 4.55 | 4.34 | 3.02 | 4.22 | 4.90 | 4.41 |
EBITDA | 3.79B | 3.67B | 3.51B | 3.17B | 3.54B | 3.41B |
EBIT | 3.21B | 3.09B | 2.9B | 2.53B | 2.92B | 2.78B |
Depreciation & Amortization | 578M | 580M | 610M | 633M | 625M | 630M |
Add to Watchlist
Select watchlists to add or remove GEHC